BioConsortia has secured a $15 million equity investment to accelerate the commercialization of its microbial seed treatments and expand its agricultural biological products into international markets. The Davis, California-based company received the investment from an entity affiliated with John Pasquesi, managing member of existing investor Otter Capital. The funding will support manufacturing capacity, regulatory approvals, commercial operati…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.